Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
03.01. | IRLAB Therapeutics - End-of-Phase II FDA meeting set | 411 | Edison Investment Research | IRLAB Therapeutics has scheduled an end-of-Phase II (EoP2) meeting (on 20 February 2024) with the US FDA for the mesdopetam programme. This marks an important milestone for IRLAB as it will evaluate... ► Artikel lesen | |
03.01. | Sequana Medical - PMA application submitted to FDA for alfapump | 292 | Edison Investment Research | Sequana Medical announced in late December that it has submitted a Premarket Approval (PMA) application to the US FDA regarding its alfapump device for use in patients with recurrent and refractory... ► Artikel lesen | |
03.01. | Sareum Holdings - SRA737 - new partnership to kick off the year | 319 | Edison Investment Research | Sareum Holdings' co-development partner CRT Pioneer Fund (CPF) has signed a new licensing agreement with an unnamed US-based private biopharma company for SRA737, its Phase II stage CHK1 inhibitor targeting... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 327 |
EVOTEC | 291 |
TUI | 209 |
NVIDIA | 176 |
DEUTSCHE BANK | 170 |
BAYER | 153 |
PLUG POWER | 143 |
NEL | 133 |
RHEINMETALL | 127 |
SIEMENS ENERGY | 110 |
BARRICK GOLD | 109 |
COMMERZBANK | 107 |
TESLA | 102 |
BASF | 101 |
VOLKSWAGEN | 93 |
RWE | 89 |
BYD | 86 |
DEUTSCHE LUFTHANSA | 84 |
ALLIANZ | 82 |
RENK GROUP | 79 |
MERCEDES-BENZ | 77 |
DEUTSCHE TELEKOM | 75 |
HEIDELBERGER DRUCK | 75 |
ALIBABA | 70 |
E.ON | 69 |